AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons






